Avita Medical | 1811094D - Ebitda



Avita Medical reported AUD-9863000 in EBITDA for its fiscal semester ending in December of 2024.


Ebitda Change Date
Celltrion KRW 221.03B 57.43B Mar/2025
Clinuvel Pharmaceuticals AUD 40.01M 21.64M Jun/2024
Cochlear AUD 323M 24.1M Dec/2024
CSL USD 3.23B 1.52B Dec/2024
Cspc Pharmaceutical CNY 2.19B 21.88M Dec/2024
Dianthus Therapeutics USD -34828000 2.99M Jun/2025
Divis Laboratories Ltd 7.29B 2.43B Jun/2025
Kangmei Pharma -3262057.35 15.91M Sep/2024
Knight Therapeutics CAD 16.72M 1.05M Sep/2024
Laboratorios Farma EUR 34.94M 102.95M Jun/2025
Malin Corporation EUR -1100000 200K Dec/2024
Mayne Pharma AUD -65761000 45.24M Jun/2024
Medical Developments International AUD 1.78M 3.78M Dec/2024
Nanosonics AUD 11.36M 2.36M Dec/2024
Neuren Pharmaceuticals AUD 176.7M 166.79M Dec/2024
Organigram Holdings CAD 2.68M 18.86M Jun/2025
Pacific Edge NZD -13968000 332K Sep/2024
Paradigm Biopharmaceuticals AUD -5859230 3.79M Dec/2024
Pharma Mar EUR 26.15M 27.2M Jun/2025
Polynovo AUD 2.86M 1.12M Jun/2024
PYC Therapeutics AUD -25596250 3.68M Dec/2024
Qiagen NV USD 208.98M 38.23M Jun/2025
Ramsay Health Care AUD 1.02B 22.3M Dec/2024
ResMed USD 530.86M 57.71M Jun/2025
Sartorius EUR 264.3M 1.3M Jun/2025
Sino Biopharmaceutical CNY 2.59B 1.57B Dec/2024
Telix Pharmaceuticals AUD 33.24M 21.45M Jun/2025
Tilray USD -101000 2.32M Nov/2024
Zhangzhou Pientzehuang Pharmaceutical 1.19B 829.65M Mar/2025